Michael Halpin
Chief Operating Officer bij VERICEL CORPORATION
Vermogen: 43 350 $ op 29-02-2024
Profiel
Presently, Michael Halpin occupies the position of Chief Operating Officer at Vericel Corp.
In the past Mr. Halpin occupied the position of Vice President-Regulatory Affairs for Genzyme Corp.
and Vice President-North American Region Regulatory at Sanofi Corp.
He received an undergraduate degree and a graduate degree from the University of Virginia.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
VERICEL CORPORATION
0.00% | 11-03-2024 | 949 ( 0.00% ) | 43 350 $ | 29-02-2024 |
Actieve functies van Michael Halpin
Bedrijven | Functie | Begin |
---|---|---|
VERICEL CORPORATION | Chief Operating Officer | 15-06-2019 |
Eerdere bekende functies van Michael Halpin
Bedrijven | Functie | Einde |
---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | General Counsel | - |
Sanofi Corp. | Corporate Officer/Principal | - |
Opleiding van Michael Halpin
University of Virginia | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
VERICEL CORPORATION | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi Corp. |